CFM
TMCI icon

Catalyst Funds Management’s Treace Medical Concepts TMCI Stock Holding History

Catalyst Funds Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$115K Buy
+28,800
New +$79.2K 0.01% 609
2024
Q3 		– Sell
-600
Closed -$3.99K – 1602
2024
Q2 		$3.99K Buy
600
+500
+500% +$4.04K ﹤0.01% 1083
2024
Q1 		$1.3K Buy
+100
New +$1.33K ﹤0.01% 1064

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Catalyst Funds Management's TMCI Position: Q2 2026 in Review

Catalyst Funds Management opened a new position in Treace Medical Concepts (TMCI) in Q2 2026: 28,800 shares worth $115K. The stake represents 0.01% of the portfolio and ranks #609 among its holdings. This is a return to the name: Catalyst Funds Management previously reported a position in TMCI as recently as Q2 2024.

Catalyst Funds Management first reported a position in TMCI in Q1 2024 and has held it in 3 quarters since. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Catalyst Funds Management held 28,800 shares of Treace Medical Concepts worth $115K as of Q2 2026.
  • Treace Medical Concepts was a new Catalyst Funds Management position in Q2 2026.
  • Treace Medical Concepts made up 0.01% of Catalyst Funds Management's portfolio in Q2 2026, its #609 holding.
  • Catalyst Funds Management first reported a position in Treace Medical Concepts in Q1 2024 and has held it in 3 quarters since.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.